Is Sresta Natural Bioproducts a good quality company?

Data is not available for this company.

What is Sresta Natural Bioproducts share price return in the past 10 years?

Data is not available for this company

What is the P/E ratio of Sresta Natural Bioproducts?

The latest standalone P/E ratio of Sresta Natural Bioproducts as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Sresta Natural Bioproducts?

The latest standalone P/B ratio of Sresta Natural Bioproducts as of 01-Jan-1970 is 0.00.

What is the 52-week high and low of Sresta Natural Bioproducts?

The 52-week high of Sresta Natural Bioproducts is Rs. and the 52-week low is Rs. .

Sresta Natural Bioproducts Ltd - Stock Valuation and Financial Performance

Name: Sresta Natural Bioproducts
Brand: Sresta Natural Bioproducts

BSE: 0 | NSE: | Agriculture | Small Cap

Place order

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Sresta Natural Bio.

Based on:

Data

DeciZen not available for IPO

10 Year X-Ray of Sresta Natural Bio.:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis ^P

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	TTM
ROCE % ⓘ	-19.9%	2.2%	0%	0.6%	0.4%	2%	1.3%	-5.3%	-2.9%	0.6%	-
Value Creation Index ⓘ	-2.4	-0.8	-1.0	-1.0	-1.0	-0.9	-0.9	-1.4	-1.2	-1.0	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	10.1	16.1	29.7	47	79.6	111	156	169	169	176	176
Sales YoY Gr.	-	59.3%	84.3%	58.4%	69.6%	39.8%	40.6%	7.8%	0.1%	4.2%	-
Adj EPS ⓘ	-6.5	0.1	0	0.2	0.2	0.2	-0.7	-5.9	-4.2	-1.4	-0.7
YoY Gr.	-	NA	-88.9%	1500%	0%	37.5%	-418.2%	NA	NA	NA	-
BVPS (₹) ⓘ	6	21	24.4	27.9	33.4	47.4	59.4	54.9	50.9	48.8	47.8
Adj Net Profit ⓘ	-1.7	0	0	0.2	0.2	0.3	-1	-10.3	-7.3	-2.6	-1
Cash Flow from Ops. ⓘ	0	0	0	0	0	-19.5	-24.1	-7.9	10.7	0.9	-
Debt/CF from Ops. ⓘ	0	0	0	0	0	-0.9	-1.5	-4.4	3	42.5	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	37.4%	17.2%	4%	4.2%
Adj EPS ⓘ	NA	-254.8%	NA	NA
BVPSⓘ	26.3%	7.9%	-6.4%	-4.1%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	TTM
Return on Equity % ⓘ	-34.4	0.3	0	0.6	0.5	0.5	-1.3	-10.9	-7.8	-2.9	-1.4
Op. Profit Mgn % ⓘ	-22.7	1.1	0.6	0.6	0.3	5.4	6.2	-5	5.3	8.6	NAN
Net Profit Mgn % ⓘ	-16.8	0.1	0	0.4	0.3	0.3	-0.7	-6.1	-4.3	-1.5	-0.7
Debt to Equity ⓘ	1.1	0.3	0.1	0.1	0.3	0.3	0.4	0.4	0.4	0.4	-
Working Cap Days ⓘ	149	166	204	217	203	245	254	265	263	261	0
Cash Conv. Cycle ⓘ	130	144	510	845	-1,041	128	135	161	131	112	0

Recent Performance Summary

Recent Performance Summary not available for IPO

Latest Financials - Sresta Natural Bioproducts Ltd.

	Standalone	Consolidated
TTM EPS (₹)	-0.7	0
TTM Sales (₹ Cr.)	176	0
BVPS (₹.) ⓘ	47.8	10
Reserves (₹ Cr.) ⓘ	71	-
P/BV ⓘ	0.00	0.00
PE ⓘ	0.00	0.00

From the Market
52 Week Low / High (₹)	- / -
All Time Low / High (₹)	- / -
Market Cap (₹ Cr.)	0
Equity (₹ Cr.)	18.8
Face Value (₹)	10
Industry PE ⓘ	26.4

Management X-Ray of Sresta Natural Bio.:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of Sresta Natural Bio.

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Sresta Natural Bio.

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Sales	10.10	16.09	29.65	46.96	79.63	111.29	156.42	168.54	168.64	175.78
Operating Expenses ⓘ	12.39	15.92	29.47	46.68	79.42	105.29	146.67	178.02	159.74	160.64
Manufacturing Costs	0.08	0.09	0	0	0	7.68	10.85	13.47	1.74	1.70
Material Costs	8.10	10.57	-3.98	-0.27	-5.84	65.68	89.95	96.24	92.08	87.56
Employee Cost	1.60	2.57	0	0	0	3.58	5.74	9.29	9.96	10.09
Other Costs ⓘ	2.61	2.68	33.46	46.95	85.26	28.35	40.14	59.02	55.96	61.29
Operating Profit ⓘ	-2.29	0.17	0.18	0.28	0.21	6	9.75	-9.48	8.90	15.14
Operating Profit Margin (%)	-22.7%	1.1%	0.6%	0.6%	0.3%	5.4%	6.2%	-5.6%	5.3%	8.6%
Other Income ⓘ	0.30	0.38	0	0	0	2.33	3.24	1.20	1.54	2.72
Interest ⓘ	0.24	0.34	0	0	0	1.68	3.47	4.85	5.26	4.67
Depreciation ⓘ	0.14	0.16	0	0	0	5.86	8.62	1.38	12.89	14.73
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	-2.38	0.06	0.18	0.28	0.21	0.78	0.89	-14.51	-7.71	-1.55
Tax ⓘ	-0.68	0.03	0.17	0.09	0	0.29	1.45	-3.65	-0.71	-0.29
Profit After Tax	-1.70	0.02	0.01	0.19	0.21	0.49	-0.55	-10.87	-7	-1.26
PAT Margin (%)	-16.8%	0.1%	0.0%	0.4%	0.3%	0.4%	-0.4%	-6.4%	-4.2%	-0.7%
Adjusted EPS (₹)	-6.5	0.1	0.0	0.2	0.2	0.3	-0.4	-6.2	-4.0	-0.7
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Equity and Liabilities
Shareholders Fund	4.25	11.27	26.37	34.60	45.23	71.33	91.25	97.17	90.25	89.06
Share Capital ⓘ	5.30	7.67	10.83	13.32	14.71	17.53	19.29	18.78	18.81	18.25
Reserves ⓘ	-1.05	3.60	15.54	21.28	30.52	53.80	71.96	78.39	71.45	70.81
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	4.51	2.78	1.58	2.50	14.39	17.47	35.45	29.49	25.86	31.53
Long Term Debt	4.51	2.78	0	0	0	3	5.54	5.02	4.90	2.34
Short Term Debt	0	0	1.58	2.50	14.39	14.48	29.91	24.46	20.95	29.19
Trade Payables	0.18	0.88	1.61	3.97	5.95	19.65	15.83	14.84	27.15	28.68
Others Liabilities ⓘ	-2.43	-2.38	-0.54	-0.24	0.43	2.13	7.79	7.21	7.50	8.61
Total Liabilities ⓘ	6.51	12.55	29.01	40.82	66	110.58	150.32	148.71	150.76	157.88
Fixed Assets
Gross Block	1.54	1.72	3.21	4.89	5.23	10.89	20.20	22.13	23	23.04
Accumulated Depreciation	0.36	0.52	0.72	1	1.33	1.95	2.93	4.31	5.71	6.66
Net Fixed Assetsⓘ	1.17	1.20	2.49	3.89	3.90	8.94	17.27	17.82	17.30	16.39
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0
Investmentsⓘ	0.59	0.59	3.02	3.72	6.03	5.49	5.49	5.49	5.20	5.20
Inventories	2.12	4.23	9.28	13.16	18.69	38.96	48.15	41.38	33.88	43.40
Trade Receivables	2.34	5.10	6.56	10.18	21.14	24.52	43.75	46.78	52.41	48.80
Cash Equivalents	0.10	0.03	0.37	0.55	0.28	2.41	3.29	4.90	5.86	7.18
Others Assetsⓘ	0.19	1.39	7.29	9.32	15.96	30.26	32.38	32.33	36.11	36.92
Total Assets ⓘ	6.51	12.55	29.01	40.82	66	110.58	150.32	148.71	150.76	157.88

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Cash Flow From Operating Activity ⓘ	-19.48	-24.13	-7.91	10.70	0.91
PBT ⓘ	0.78	0.89	-14.51	-7.71	-1.55
Adjustment ⓘ	-1.03	-0.66	12.41	4.10	7.58
Changes in Working Capital ⓘ	-19.24	-24.37	5.19	13.6	-5.26
Tax Paid ⓘ	0	0	3.56	0.71	0.14
Cash Flow From Investing Activity ⓘ	-5.66	-8.52	-2.47	-0.88	-0.61
Capex	-5.66	-9.33	-1.95	-0.88	-0.61
Net Investments	0	0	0	0	0
Others ⓘ	0	0.81	-0.51	0	0
Cash Flow From Financing Activityⓘ	27.44	33.53	11.99	-8.86	1.02
Net Proceeds from Shares ⓘ	25.15	1.76	0.11	0.03	0.02
Net Proceeds from Borrowing ⓘ	0	0	0	0	0
Interest Paid ⓘ	-1.57	-3.26	-4.52	-5.01	-4.40
Dividend Paid ⓘ	0	0	0	0	0
Others ⓘ	3.86	35.03	16.40	-3.88	5.40
Net Cash Flow ⓘ	2.30	0.88	1.61	0.96	1.32

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Ratios
ROE (%)	-76.62	0.63	0.04	0.65	0.54	0.88	-0.72	-11.92	-7.58	-1.42
ROCE (%)	-27.76	3.52	0.87	0.86	0.43	3.32	4.05	-7.46	-1.92	2.49
Asset Turnover Ratio	1.73	1.69	1.43	1.34	1.49	1.26	1.2	1.13	1.13	1.14
PAT to CFO Conversion(x)	N/A	0	0	-102.53	-114.9	-16.14	N/A	N/A	N/A	N/A
Working Capital Days
Receivable Days	50	84	72	65	72	75	80	98	107	105
Inventory Days	92	72	83	87	73	95	102	97	81	80
Payable Days	18	18	-114	-3,821	-310	71	72	58	83	116

Sresta Natural Bioproducts Ltd Stock News

Sresta Natural Bioproducts Ltd FAQs

What is the share price of Sresta Natural Bio.?

Company share prices are keep on changing according to the market conditions. The closing price of Sresta Natural Bio. on 01-Jan-1970 05:30 is ₹0.00.

What is the market cap of Sresta Natural Bio.?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Sresta Natural Bio. stood at ₹0.00.